DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

Clinical trial NCT05770544 · RECRUITING

Trial details

NCT number: NCT05770544
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Haematological Malignancy Malignancy Malignant Neoplasm Lymphoproliferative Disorders Neoplasms by Histologic Type Neoplasms by Site Cancer Brain Neoplasms Melanoma Glioma Solid Tumour

Start date: 2025-11-30
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.